Compounds Included in this Protocol: Semax (10mg): A synthetic heptapeptide analog of ACTH(4-7). Engineered to modulate central nervous system function, it is primarily studied for its neuroprotective properties, neuroplasticity promotion, and its ability to significantly upregulate Brain-Derived Neurotrophic Factor (BDNF). Selank (10mg): A stabilized analogue of the endogenous tetrapeptide tuftsin. It exhibits unique nootropic and anxiolytic properties in clinical research, widely studied for its potential to modulate the stress axis and immune system without causing sedation. NAD+ (500mg): Nicotinamide Adenine Dinucleotide. A critical coenzyme essential to cellular energy metabolism. It acts as the metabolic foundation for this stack, studied for its role in mitochondrial function, neuro-repair, and healthy aging pathways. In clinical research, this stack is utilized to observe complete cognitive and neurovascular optimization. Semax acts as the neurological stimulant (upregulating BDNF and focus), Selank acts as the modulator (smoothing out the stress axis and preventing over-excitation), and NAD+ acts as the underlying fuel source (providing the raw cellular energy required for intense neuroplasticity). Together, they form an elite matrix for advanced nootropic research. Purity & Verification: All compounds in this protocol are synthesized to a strict ≥99% purity standard, verified via independent third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).